Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01203813 · ClinicalTrials.gov registry record · Phase 3
A Risk Based Approach to Improving Chronic Kidney Disease Management
A Phase 3 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 10,000
- Enrollment target
NCT01203813 is a Phase 3 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 10,000 participants.
The verdict
NCT01203813, a Phase 3 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 10,000 participants
- Enrollment target
Study Summary
Aim 1: To assess whether quality of care for stage 3 chronic kidney disease can be substantially improved over 18 months by: * Point of care electronic alerts to primary care physicians recommending risk-appropriate care, and * Quarterly mailings to patients providing self management support materials, including tailored recommendations based on personalized data from an electronic disease registry Aim 2: To assess the relationship between utilization of the intervention components and primary care physician attitudes towards both chronic kidney disease management and electronic reminder systems.
Interventions
- OTHER Electronic Decision Support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2011-05 |
| Est. Completion | 2013-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01203813
The ClinicalTrials.gov registry entry for NCT01203813 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Electronic Decision Support is the first listed.
NCT01203813 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01203813 about?
NCT01203813 is a clinical study titled "A Risk Based Approach to Improving Chronic Kidney Disease Management". Aim 1: To assess whether quality of care for stage 3 chronic kidney disease can be substantially improved over 18 months by: * Point of care electronic alerts to primary care physicians recommending risk-appropriate care, and * Quarterly mailings to patients providing self management support materi...
What is the current status of trial NCT01203813?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 10,000 participants. The study started on 2011-05. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01203813?
The interventions under investigation include: Electronic Decision Support (OTHER).
Who is sponsoring clinical trial NCT01203813?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.